Tufts Report Shines Light on Continued Use, Cost of Clinical Trial Protocol Changes

Drug Industry Daily
Tweaking even one part of a clinical trial’s protocol — which happens more than half of the time in global trials — takes a toll on research, according to an analysis from the Tufts Center for the Study of Drug Development.

To View This Article:


Subscribe To Drug Industry Daily